OrthoTrophix, Inc., a privately held biopharmaceutical company, today announced the initiation of a Phase 2b clinical trial of TPX-100, its lead therapeutic candidate, in patients with mild to severe ...

Press release First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease HER-096 is a first-in-class agent in development for the treatment of Parkinson’s ...

Herantis Pharma Plc - Press release First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson's disease HER-096 is a first-in-class agent in development for ...

Pasithea Therapeutics Announces Initiation of Phase 1/1B Study of PAS-004 in Adult NF1 Patients and Activation of First ...

Adds nine additional countries to the Company's ongoing pivotal Phase 3 trial; Authorization granted in all EU countries requested Enrollment and dosing underway in Phase 3 clinical trial (the "MIRACL ...

Close collaboration between researchers and clinicians at Mayo is what makes the steps of translation — from discovery to the ...

Espoo, Finland, 13 May 2025: Herantis Pharma Plc ("Herantis"), a company developing disease-modifying therapies for Parkinson's disease, today announced the first patients have been dosed in the final ...

Advanced analytics leverages machine learning (ML), statistical modeling, data mining and visualizations to empower ...

Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Trial in COVID-19 ...

Autonomix Medical, Inc. has announced its plans to commence a follow-on phase of its proof-of-concept clinical trial, known as PoC 2, which is set to begin in Q2 2025. This phase will further ...

During the quiet hours of sleep, your brain is hard at work. It sends out tiny electrical signals that ripple across networks ...

Zynlonta manufacturer ADC Therapeutics is continuing to prune its pipeline, calling time on its sole clinical-stage candidate ...